Literature DB >> 18240314

P2X(7) receptor stimulation in primary cultures of rat spinal microglia induces downregulation of the activity for glutamate transport.

Norimitsu Morioka1, Md Joynal Abdin, Tomoya Kitayama, Katsuya Morita, Yoshihiro Nakata, Toshihiro Dohi.   

Abstract

It has been shown that spinal microglia expressing certain types of glutamate transporters function in the modulation of neuropathogenesis. In this study, the effect of ATP, potentially able to mediate the communication between neurons and glial cells in the spinal cord on the transport of glutamate in cultured spinal microglia, was investigated. Both GLAST and GLT-1 were detected in the cells. Preincubation with ATP or 2'-3'-O-(4-benzoyl-benzoyl) ATP (BzATP), a selective agonist for the P2X(7) receptor, significantly blocked the uptake of glutamate. The effect of BzATP was reversed by pretreatment with brilliant blue G or oxidized ATP, each a selective antagonist for P2X(7). The inhibitory effect of P2X(7) receptor activation also occurred in the absence of extracellular Na(+) or Ca(2+), suggesting that the receptor regulates glutamate transport by a metabotropic pathway. Furthermore, pretreatment with inhibitors of mitogen-activated protein kinase kinase, or antioxidants, significantly reversed the inhibitory effect of BzATP on the uptake of glutamate. Incubation with BzATP led to a marked decrease in the V(max), but not the K(m), of glutamate transport. However, treatment with BzATP did not induce the trafficking of glutamate transporters. These results suggest that the activation of P2X(7) receptors in spinal microglia is important in the regulation of glutamate transport via activation of the extracellular signal-regulated kinase cascade and production of oxidants.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18240314     DOI: 10.1002/glia.20634

Source DB:  PubMed          Journal:  Glia        ISSN: 0894-1491            Impact factor:   7.452


  9 in total

1.  Involvement of spinal microglial P2X7 receptor in generation of tolerance to morphine analgesia in rats.

Authors:  Dong Zhou; Meng-Ling Chen; Yu-Qiu Zhang; Zhi-Qi Zhao
Journal:  J Neurosci       Date:  2010-06-09       Impact factor: 6.167

2.  Estrogen and P2 Purinergic Receptor Systems in Microglia: Therapeutic Targets for Neuroprotection.

Authors:  Jessica M Crain; Jyoti J Watters
Journal:  Open Drug Discov J       Date:  2010-01-01

3.  Physiological and pathological functions of P2X7 receptor in the spinal cord.

Authors:  Maria Luisa Cotrina; Maiken Nedergaard
Journal:  Purinergic Signal       Date:  2009-02-11       Impact factor: 3.765

Review 4.  Microglia dynamics and function in the CNS.

Authors:  Christopher N Parkhurst; Wen-Biao Gan
Journal:  Curr Opin Neurobiol       Date:  2010-08-10       Impact factor: 6.627

5.  P2X Purinergic Receptors Are Multisensory Detectors for Micro-Environmental Stimuli That Control Migration of Tumoral Endothelium.

Authors:  Giorgia Scarpellino; Tullio Genova; Elisa Quarta; Carla Distasi; Marianna Dionisi; Alessandra Fiorio Pla; Luca Munaron
Journal:  Cancers (Basel)       Date:  2022-05-31       Impact factor: 6.575

6.  Activation of proprotein convertase in the mouse habenula causes depressive-like behaviors through remodeling of extracellular matrix.

Authors:  Hikaru Ito; Kanako Nozaki; Kenji Sakimura; Manabu Abe; Shigeto Yamawaki; Hidenori Aizawa
Journal:  Neuropsychopharmacology       Date:  2020-09-17       Impact factor: 7.853

7.  The role of purinergic receptors in cancer-induced bone pain.

Authors:  Sarah Falk; Maria Uldall; Anne-Marie Heegaard
Journal:  J Osteoporos       Date:  2012-10-03

Review 8.  P2X7 Receptor-Associated Programmed Cell Death in the Pathophysiology of Hemorrhagic Stroke.

Authors:  Hengli Zhao; Yujie Chen; Hua Feng
Journal:  Curr Neuropharmacol       Date:  2018       Impact factor: 7.363

9.  Ischemia-Triggered Glutamate Excitotoxicity From the Perspective of Glial Cells.

Authors:  Denisa Belov Kirdajova; Jan Kriska; Jana Tureckova; Miroslava Anderova
Journal:  Front Cell Neurosci       Date:  2020-03-19       Impact factor: 5.505

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.